BiomeMega

We use bacteria to obtain sustainable ingredients requested by industry.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Sydney NSW, Australia
  • Currency AUD
  • Founded August 2023
  • Employees 5
  • Incorporation Type C-corp
  • Website biomemega.com

Company Summary

We obtain Omega ingredients from probiotic bacteria as requested by industry partners. We receive Blackmores mentoring and signed MoU, and through Medtech Actuator we discuss new partnerships. Cicada Innovation coaches us to pitch to L'Oreal, and Kings School provides new equipped PC2 labs and non-dilutive cash. We also offer consulting to help pay for our expenses. Next, we need investment to conduct tests for our first TGA regulatory approval.

Team

  • Gustavo De Cerqueira
    CEO

    Molecular Microbiology experience since 2001, PhD in Biotechnology by the Pasteur Institute and a prestigious Brazilian university, postdoctoral positions in three International institutes, lecturer of microbiology and immunology at JCU, visiting scientist at UConn-Health Center, BigPharma scientist at Butantan Institute (vaccines supplier), Cluster Biotechnology manager until 2023 receiving $1.5M in grants and up to $700K/annum from industry.

  • Fraser Taylor
    Co-Founder

    Fraser Taylor (www.linkedin.com/in/fraser-taylor-aa47551/) is an experienced company director who will be listed a BiomeMega executive Director in July 2024. Fraser has previously worked for Nestle, Kellogg’s and other groups in operational and commercial leadership roles across three international markets, and he has completed 90% of an UK-based MBA as part of his Master’s degree. Fraser will work hands-on in business admin.

Advisors

  • Peter Valtchev
    Dr Vladimir Stajic - Blackmores Group Director of Research and Technical Affairs, providing mentoring towards Omega development with health function and clinical evidence (market advantages).
    Unconfirmed
    Prof Ian Paulsen from Macquarie University is an advisor of Synthetic Biology, and an agreement has been signed which will promote our joint growth and support BiomeMega's access to fully equipped OGTR-accredited facilities upon capital raise.
    Unconfirmed
  • Lee Miles
    Mark Nichols
    Unconfirmed

Previous Investors

  • Mr Murugesh Sheekar has invested $10,000 as an initial cash contribution, and contributed $10,000 +gst worth of accounting services during pre-seed stage. The expectation is that funds are returned once sales revenue is achieved.
    Unconfirmed
    Mr Mark Bouw has invested $10,000 as an initial cash contribution, and contributed $25,000 +gst worth of strategy and marketing services during pre-seed stage. The expectation is that funds are returned once sales revenue is achieved.
    Unconfirmed
    Mr Paul Montgomery has invested $15,000 as an initial cash contribution, and contributed $11,000 +gst worth of governance and legal services during pre-seed stage. The expectation is that funds are returned once sales revenue is achieved.
    Unconfirmed
  • Mr Mario Maia has invested $50,000 +gst worth of capital raise preparedness services during pre-seed stage. The expectation is that funds are returned once sales revenue is achieved.
    Unconfirmed
    Mr Paul Jones has invested $8,000 +gst worth of PCT patent preparation services during pre-seed stage. The expectation is that his invoice is paid upon capital raise.
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free